Pfizer-BioNTech COVID-19 vaccine gains full U.S. regulatory approval

14 Sept 04:37 Key points summarised by AI

The U.S. Food and Drug Administration (FDA) granted full regulatory approval to the Pfizer-BioNTech COVID-19 vaccine for individuals aged 16 and older, making it the first vaccine to achieve this status in the U.S.
President Joe Biden urged unvaccinated Americans to get the shot, anticipating that the full approval would boost public confidence and lead to more vaccine mandates from employers, states, and the military.
Based on updated clinical trial data, the FDA's decision affirms the vaccine's efficacy and safety profile, while also extending its shelf life and potentially simplifying off-label use for third doses in certain populations.

Sihasak urges Thais in Europe to stay alert as protests spread

Yesterday 12:06 Key points summarised by AI

Thai Foreign Minister Sihasak Phuangketkeow advises Thai nationals in Europe to avoid protest areas and reconsider non-essential travel, citing widespread unrest in countries like France, Italy, and Spain.
The warning comes as demonstrations escalate, with some turning violent, prompting concerns for safety and leading to an emergency Cabinet meeting in Italy and a proposed postponement of diplomatic talks.
Thai embassies and the Department of Consular Affairs issue advisories, urging citizens to monitor local developments, follow official announcements, and register their travel details for assistance, while emphasizing that no Thais have been directly affected yet.